{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:02:57Z","timestamp":1771002177742,"version":"3.50.1"},"reference-count":27,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T00:00:00Z","timestamp":1393372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Obstet and Gynaecol"],"published-print":{"date-parts":[[2014,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>Pregnancy and delivery are affected by and \u2013 in turn \u2013 impact signs and symptoms of Gaucher disease (<jats:styled-content style=\"fixed-case\">GD<\/jats:styled-content>). Prior to enzyme replacement therapy (<jats:styled-content style=\"fixed-case\">ERT<\/jats:styled-content>), the reported missed abortions rate was 25%, with worsening of anemia and thrombocytopenia, with increased frequency of post\u2010partum hemorrhage, puerperal fever and bone crises during pregnancy. <jats:styled-content style=\"fixed-case\">ERT<\/jats:styled-content> with imiglucerase reduced these adverse events. Velaglucerase alfa (<jats:styled-content style=\"fixed-case\">VPRIV<\/jats:styled-content>), an <jats:styled-content style=\"fixed-case\">ERT<\/jats:styled-content> approved commercially in <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>ebruary 2010, had undergone preclinical reproductive toxicity testing and proven to be safe and effective in phase <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">II<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">III<\/jats:styled-content> clinical trials. The objective of this study was to ascertain pregnancy outcome in women receiving <jats:styled-content style=\"fixed-case\">VPRIV<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Among records collected from six multinational clinical sites, 21 females (mean age, 32.0\u2009years) with <jats:styled-content style=\"fixed-case\">GD<\/jats:styled-content> received <jats:styled-content style=\"fixed-case\">VPRIV<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 25 singleton pregnancies (mean gravidity, 2.7; mean parity, 2.0; mean months <jats:styled-content style=\"fixed-case\">VPRIV<\/jats:styled-content>, 31.2). Two primiparous women suffered three first trimester abortions and one missed abortion occurred in a multigravida female. Live birth rate was 84% (mean gestational age, 39.7\u2009weeks). Mean birthweight was 3234.4\u2009g, with <jats:styled-content style=\"fixed-case\">APGAR<\/jats:styled-content> scores above 9. All but three were vaginal deliveries; elective cesarean sections were performed in two patients with hip arthroplasty and one after previous cesarean. Nine patients received regional analgesia\/anesthesia. Post\u2010partum complications were rare, with only one post\u2010partum (placental) bleed which resolved without intervention. Mean hemoglobin and platelet counts improved during pregnancy (9.45% and 26.0%, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">VPRIV<\/jats:styled-content> is safe for conception and pregnancy with good maternal and neonatal outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jog.12254","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T02:26:40Z","timestamp":1393381600000},"page":"968-975","source":"Crossref","is-referenced-by-count":24,"title":["Outcome of pregnancies in women receiving velaglucerase alfa for <scp>G<\/scp>aucher disease"],"prefix":"10.1111","volume":"40","author":[{"given":"Deborah","family":"Elstein","sequence":"first","affiliation":[{"name":"Gaucher Clinic Shaare Zedek Medical Center, affiliated with the Hadassah Medical Center\u2010Hebrew University Medical School  Jerusalem Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derralynn","family":"Hughes","sequence":"additional","affiliation":[{"name":"Hematology Service Royal Free Hospital University College London School of Medicine  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"Goker\u2010Alpan","sequence":"additional","affiliation":[{"name":"Lysosomal Disorders Research and Treatment Unit O &amp; O Alpan LLC  Fairfax Virginia USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Stivel","sequence":"additional","affiliation":[{"name":"Hematology Service Hospital Guillermo Rawson  San Juan Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagit N.","family":"Baris","sequence":"additional","affiliation":[{"name":"Gaucher Center The Raphael Recanati Genetic Institute Rabin Medical Center Beilinson Hospital  Petach Tikva Israel"},{"name":"Sackler School of Medicine Tel Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian J.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Gaucher Center The Raphael Recanati Genetic Institute Rabin Medical Center Beilinson Hospital  Petach Tikva Israel"},{"name":"Sackler School of Medicine Tel Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorina","family":"Granovsky\u2010Grisaru","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Shaare Zedek Medical Center, affiliated with the Hadassah Medical Center\u2010Hebrew University Medical School  Jerusalem Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon","family":"Samueloff","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Shaare Zedek Medical Center, affiliated with the Hadassah Medical Center\u2010Hebrew University Medical School  Jerusalem Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Mehta","sequence":"additional","affiliation":[{"name":"Hematology Service Royal Free Hospital University College London School of Medicine  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"Zimran","sequence":"additional","affiliation":[{"name":"Gaucher Clinic Shaare Zedek Medical Center, affiliated with the Hadassah Medical Center\u2010Hebrew University Medical School  Jerusalem Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,2,26]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"1065","volume-title":"Williams Hematology","author":"Zimran A","year":"2010"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105233242104"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(97)70099-1"},{"key":"e_1_2_6_5_1","first-page":"852","article-title":"Alglucerase enzyme replacement therapy used safely and effectively throughout the whole pregnancy of a Gaucher disease patient","volume":"83","author":"Aporta Rodriguez R","year":"1998","journal-title":"Haematologica"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.107203"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-002-0431-1"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1516-31802002000300008"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2003.08.006"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)91494-3"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199906)61:2<103::AID-AJH5>3.0.CO;2-V"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-07-0503"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-008-0779-z"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2009.04.003"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2010.12.024"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-268649"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2009.09.006"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2009.12.001"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijoa.2004.05.003"},{"key":"e_1_2_6_20_1","unstructured":"FDA: Food and Drug Administration Center for Evaluation and Research Pregnancy Labeling Subcommittee of the Advisory Committee for Reproductive Health Drugs. [Cited 26 Mar 2001.] Available from URL:http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/00\/transcripts\/3601tl.rtf"},{"key":"e_1_2_6_21_1","unstructured":"Guideline on the exposure to medicinal products: Need for post\u2010authorisation data (EMEA\/CHMP\/313666\/2005)."},{"key":"e_1_2_6_22_1","unstructured":"VPRIV\u00ae package insert Shire HGT Lexington MA."},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.4155\/cli.10.21"},{"key":"e_1_2_6_24_1","first-page":"306","volume-title":"Current Obstetric & Gynecologic Diagnosis & Treatment","author":"Pernoll ML","year":"2003"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2011.09.009"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2010.11.008"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1552-6909.1998.tb02594.x"},{"issue":"108","key":"e_1_2_6_28_1","first-page":"1000108","article-title":"Pregnancy and protection: The ethics of limiting a pregnant woman's participation in clinical trials","volume":"2","author":"Allesee L","year":"2011","journal-title":"J Clin Res Bioeth"}],"container-title":["Journal of Obstetrics and Gynaecology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjog.12254","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjog.12254","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jog.12254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T06:27:23Z","timestamp":1759213643000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/jog.12254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,26]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["10.1111\/jog.12254"],"URL":"https:\/\/doi.org\/10.1111\/jog.12254","archive":["Portico"],"relation":{},"ISSN":["1341-8076","1447-0756"],"issn-type":[{"value":"1341-8076","type":"print"},{"value":"1447-0756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,26]]}}}